Recent 13F filings as of December 2025 show that 119 institutional investors hold a position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Artal Group S.A. | 31 Dec, 2025 | 136,180,481 | 0 | 0.00% | $156,607,553.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 38,918,903 | 0 | 0.00% | $44,756,738.00 |
| FMR LLC | 31 Dec, 2025 | 37,834,207 | -845,541 | -2.19% | $43,509,338.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 9,606,549 | 84,675 | 0.89% | $11,047,532.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 4,821,733 | 991,073 | 25.87% | $5,544,993.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,192,448 | -202,524 | -5.97% | $3,671,316.00 |
| UBS Group AG | 31 Dec, 2025 | 3,007,237 | 2,654,315 | 752.10% | $3,458,322.00 |
| Sessa Capital IM, L.P. | 31 Dec, 2025 | 3,000,000 | 0 | 0.00% | $3,450,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,500,022 | 102,099 | 4.26% | $2,876,410.00 |
| CIBC Private Wealth Group LLC | 31 Dec, 2025 | 1,950,000 | -450,257 | -18.76% | $2,242,500.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 1,828,404 | 1,360,574 | 290.83% | $2,102,665.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,710,975 | -923,052 | -35.04% | $1,967,621.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 1,262,367 | 1,262,367 | 0.00% | $1,451,722.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 1,207,242 | 245,182 | 25.49% | $1,388,329.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,055,123 | -89,509 | -7.82% | $1,213,391.00 |
| GSA CAPITAL PARTNERS LLP | 31 Dec, 2025 | 996,235 | -206,671 | -17.18% | $1,146.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 921,204 | 861,857 | 1,452.23% | $1,059,385.00 |
| Hennion & Walsh Asset Management, Inc. | 31 Dec, 2025 | 901,222 | 122,010 | 15.66% | $1,036,405.00 |
| STATE STREET CORP | 31 Dec, 2025 | 884,738 | 4,617 | 0.52% | $1,017,449.00 |
| Ishara Investments LP | 31 Dec, 2025 | 880,000 | 880,000 | 0.00% | $1,012,000.00 |